Cytonect develops topical therapeutics that work with the biology of the skin — starting with a next-generation anti-inflammatory pomade, with a growing pipeline to follow.
We target the inflammatory signaling that drives irritation — addressing the cause rather than masking the surface.
Stable, tolerable, manufacturable products. Good science only matters if it becomes something you can actually use.
The pomade is the first expression of a platform. New bioactive technologies are already in development.
Our work begins with a topical anti-inflammatory pomade — and extends into a pipeline of bioactive technologies.
We start at the cellular level — mapping the signaling behind inflammation and irritation.
Active ingredients are formulated into a stable topical base designed for targeted, barrier-supportive relief.
We test for stability and tolerability, refining toward a finished product ready for real-world use.
Interested in our technologies, partnerships, or what we're building next? We'd love to hear from you.